+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
540788 ASPIRA

Aspira Pathlab & Diagnostics Share Price

 

 

Aspira Pathlab & Diagnostics live price: ₹118.2. It opened at ₹119 vs previous close ₹121; intraday high/low: ₹119/₹118. The 50 & 200 DMA stand at ₹93.05/₹71.74.

Aspira Pathlab & Diagnostics Performance

  • Today's Low
  • ₹118
  • Today's High
  • ₹119
  • 52 Week Low
  • ₹49
  • 52 Week High
  • ₹136
  • Open Price₹119
  • Previous Close₹121
  • Volume131
  • 50 DMA₹93.05
  • 100 DMA₹80.07
  • 200 DMA₹71.74

Aspira Pathlab & Diagnostics Chart

Investment Returns

  • Over 1 Month + 84.98%
  • Over 3 Month + 108.76%
  • Over 6 Month + 77.74%
  • Over 1 Year + 107.37%

Smart Investing Starts Here Start SIP with Aspira Pathlab & Diagnostics for Steady Growth!

Invest Now

Aspira Pathlab & Diagnostics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 2232.3
  • PEG Ratio
  • -22.9
  • Market Cap Cr
  • 122
  • P/B Ratio
  • 9.9
  • Average True Range
  • 5.2
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 14.22
  • RSI
  • 64.17
  • MFI
  • 90.9

Aspira Pathlab & Diagnostics Financials

Aspira Pathlab & Diagnostics Technicals

EMA & SMA

Current Price
₹118.20
-2.4 (-1.99%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹113.20
  • 50 Day
  • ₹93.00
  • 100 Day
  • ₹80.10
  • 200 Day
  • ₹71.70

Resistance and Support

118.3 Pivot Speed
  • R3 118.70
  • R2 118.60
  • R1 118.40
  • S1 118.10
  • S2 118.00
  • S3 117.80

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Aspira Pathlab & Diag has an operating revenue of Rs. 24.98 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 0% needs improvement, ROE of 0% is poor and needs improvement. The company has a reasonable debt to equity of 11%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 46% and 77% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 62% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 5 which is a POOR score indicating inconsistency in earnings, a RS Rating of 97 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 29 indicates it belongs to a strong industry group of Medical-Services and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Aspira Pathlab & Diagnostics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-23 Audited Results
2026-02-10 Quarterly Results
2025-11-12 Quarterly Results
2025-08-12 Quarterly Results
2025-05-16 Audited Results

Aspira Pathlab & Diagnostics Shareholding Pattern

18.39%
60.06%
21.55%

Aspira Pathlab & Diagnostics FAQs

Aspira Pathlab & Diagnostics share price is ₹118 As on 12 June, 2026 | 04:02

The Market Cap of Aspira Pathlab & Diagnostics is ₹121.7 Cr As on 12 June, 2026 | 04:02

The P/E ratio of Aspira Pathlab & Diagnostics is 2232.3 As on 12 June, 2026 | 04:02

The PB ratio of Aspira Pathlab & Diagnostics is 9.9 As on 12 June, 2026 | 04:02

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23